Global OTC Casting and Splinting Products Market Size By Type (Casting, Splinting), By Application (Fracture, Musculoskeletal Injuries), By Region, And Segment Forecasts, 2023 to 2032

The Global OTC (Over-the-Counter) Casting and Splinting Products Market was valued at USD 4.1 billion in 2023 and is projected to reach USD 7.3 billion by 2031, growing at a CAGR of 7.1% during the forecast period of 2023-2031. The increasing prevalence of orthopedic injuries, sports-related injuries, and musculoskeletal disorders is driving the demand for OTC casting and splinting products. Additionally, the growing preference for self-care products and home treatment options, especially among aging populations, further supports market growth.

OTC casting and splinting products offer cost-effective and convenient solutions for minor fractures, sprains, and musculoskeletal support, reducing the need for hospital visits and facilitating quick recovery.

Drivers:

Rising Incidence of Orthopedic Injuries:

Increasing cases of bone fractures, ligament injuries, and soft tissue damage due to road accidents, sports activities, and aging-related bone disorders are driving market demand.

Growing Adoption of Home Healthcare Solutions:

Consumers are increasingly seeking OTC products for treating minor injuries at home to reduce healthcare expenses and avoid hospital visits.

Technological Advancements in Product Materials:

Innovations in lightweight, breathable, and water-resistant materials have improved the comfort and effectiveness of casting and splinting products, promoting higher adoption.

Restraints:

Limited Product Awareness in Developing Regions:

Lack of awareness about the availability and benefits of OTC casting and splinting products in low-income regions restricts market expansion.

Risk of Improper Application:

Incorrect use of OTC casting and splinting products may lead to complications, discouraging consumers from adopting self-care options.

Opportunity:

Expansion of E-commerce Distribution Channels:

Rising online sales of healthcare products, including orthopedic supports, provide growth opportunities for market players.

Increasing Sports Participation Globally:

Growing involvement in sports and fitness activities increases the risk of minor injuries, driving demand for OTC splints and casts for immediate care.

Market by System Type Insights:

Based on system type, the Casting Products segment accounted for the largest market share in 2023. Casting products are extensively used for immobilizing bone fractures and severe ligament injuries. However, the Splinting Products segment is expected to witness the fastest growth due to their increasing use in treating minor injuries and soft tissue support.

Market by End-use Insights:

By end-use, the Hospitals & Clinics segment dominated the market in 2023 due to higher patient inflow for injury management. The Home Care segment is projected to grow significantly during the forecast period, driven by the increasing preference for self-treatment and the availability of user-friendly OTC products.

Market by Regional Insights:

North America held the largest share of the global OTC casting and splinting products market in 2023, supported by a high prevalence of sports injuries, advanced healthcare infrastructure, and consumer awareness. Asia-Pacific is anticipated to register the highest growth rate from 2023 to 2031, driven by a growing population, rising healthcare expenditure, and increasing adoption of home healthcare solutions in countries like China and India.

Competitive Scenario:

Key players operating in the global OTC casting and splinting products market include 3M Company, Össur, Zimmer Biomet Holdings, Inc., BSN Medical, Stryker Corporation, DeRoyal Industries, Inc., DJO Global, Weber Orthopedic LP, Tynor Orthotics Pvt. Ltd., and Patterson Medical Holdings, Inc.

These companies focus on product innovation, expanding product portfolios, and strategic collaborations to strengthen their market position.

Key Market Developments:

In 2023, 3M Company introduced a new lightweight, water-resistant casting tape designed for patient comfort and faster application.

In 2024, Össur expanded its splinting product line with enhanced breathable materials for better skin comfort.

In 2025, Zimmer Biomet partnered with a digital health platform to offer guided self-application tutorials for OTC casting and splinting products.

Scope of Work – Global OTC Casting and Splinting Products Market

Report Metric Details

Market Size (2023) USD 4.1 billion

Projected Market Size (2031) USD 7.3 billion

CAGR (2023-2031) 7.1%

Market Segments By System Type (Casting Products, Splinting Products), By End-use (Hospitals & Clinics, Home Care), By Region

Growth Drivers Rising incidence of orthopedic injuries, Growing home healthcare adoption, Technological advancements in product materials

Opportunities Expansion of e-commerce distribution channels, Increasing sports participation globally

FAQs:

1) What is the current market size of the Global OTC Casting and Splinting Products Market?

The market was valued at USD 4.1 billion in